251 related articles for article (PubMed ID: 19010206)
1. Evaluation of the pretransplantation phase of the hemopoietic stem cell program in a tertiary hospital.
Márquez Malaver FJ; Espigado Tocino I; Balsalobre López P; Carmona González M; Parody Ruiz-Berdejo R; Perez-Hurtado de Mendoza JM; Urbano Ispizua A
Transplant Proc; 2008 Nov; 40(9):3099-101. PubMed ID: 19010206
[TBL] [Abstract][Full Text] [Related]
2. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
3. Effects of race on survival after stem cell transplantation.
Mielcarek M; Gooley T; Martin PJ; Chauncey TR; Young BA; Storb R; Torok-Storb B
Biol Blood Marrow Transplant; 2005 Mar; 11(3):231-9. PubMed ID: 15744242
[TBL] [Abstract][Full Text] [Related]
4. Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases. European Group for Blood and Marrow Transplantation.
Peters C; Ladenstein R; Minkov M; Pötschger U; Gadner H; Cornish J; Dini G; Klingebiel T; Locatelli F; Vossen J; Niethammer D
Bone Marrow Transplant; 1998 Sep; 22(5):431-7. PubMed ID: 9733265
[TBL] [Abstract][Full Text] [Related]
5. [The role of cost analysis in the evaluation of the development of medical technology. The case of allogenic stem-cell transplantation].
Groot MT; van Agthoven M; Löwenberg B; Willemze R; Uyl-de Groot CA
Ned Tijdschr Geneeskd; 2004 Mar; 148(10):480-4. PubMed ID: 15042895
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
7. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of 62 allogeneic stem cell transplantations; the evaluation of prognostic factor in a single institution.
Kawasaki K; Kosaka Y; Nakamura H
Kobe J Med Sci; 2003; 49(1-2):1-10. PubMed ID: 12698016
[TBL] [Abstract][Full Text] [Related]
9. Second allogeneic stem cell transplantation in myeloid malignancies.
Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
[TBL] [Abstract][Full Text] [Related]
10. Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML.
Kim HJ; Min WS; Cho BS; Eom KS; Kim SY; Kim YJ; Lee S; Min CK; Cho SG; Lee JW; Kim CC
Bone Marrow Transplant; 2009 Sep; 44(6):345-51. PubMed ID: 19270728
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience.
Jaing TH; Tsay PK; Yang CP; Hung IJ; Wen YC; Tseng CK
Transplant Proc; 2008 Dec; 40(10):3643-5. PubMed ID: 19100457
[TBL] [Abstract][Full Text] [Related]
12. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
13. Current status of hematopoietic stem cell transplantations in Vietnam.
van Be T; van Binh T; Binh N; Tuan T; Nghia H; Hien B
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S146-S148. PubMed ID: 18724291
[TBL] [Abstract][Full Text] [Related]
14. IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Nevill TJ; Shepherd JD; Sutherland HJ; Abou Mourad YR; Lavoie JC; Barnett MJ; Nantel SH; Toze CL; Hogge DE; Forrest DL; Song KW; Power MM; Nitta JY; Dai Y; Smith CA
Biol Blood Marrow Transplant; 2009 Feb; 15(2):205-13. PubMed ID: 19167680
[TBL] [Abstract][Full Text] [Related]
15. The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Bacher U; Klyuchnikov E; Zabelina T; Ottinger H; Beelen DW; Schrezenmeier H; Ehninger G; Müller C; Berger J; Suttorp M; Kolb HJ; Kröger N; Zander AR
Ann Hematol; 2009 Dec; 88(12):1237-47. PubMed ID: 19319532
[TBL] [Abstract][Full Text] [Related]
16. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark RE; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
Bone Marrow Transplant; 2008 Dec; 42(11):739-42. PubMed ID: 18724394
[TBL] [Abstract][Full Text] [Related]
17. A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation.
Brandão LR; Kletzel M; Boulad F; Kurtzberg J; Maloney K; Fligman I; Sison CP; Dimichele D
Pediatr Blood Cancer; 2008 Jun; 50(6):1240-6. PubMed ID: 18273869
[TBL] [Abstract][Full Text] [Related]
18. Reticulocyte maturation parameters are reliable early predictors of hematopoietic engraftment after allogeneic stem cell transplantation.
Molina JR; Sanchez-Garcia J; Torres A; Alvarez MA; Serrano J; Casaño J; Gomez P; Martinez F; Rodriguez A; Martin C
Biol Blood Marrow Transplant; 2007 Feb; 13(2):172-82. PubMed ID: 17241923
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation.
Boehm A; Sperr WR; Leitner G; Worel N; Oehler L; Jaeger E; Mitterbauer M; Haas OA; Valent P; Kalhs P; Rabitsch W
Eur J Clin Invest; 2008 Dec; 38(12):945-52. PubMed ID: 19021720
[TBL] [Abstract][Full Text] [Related]
20. Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation.
Kurosawa S; Fukuda T; Tajima K; Saito B; Fuji S; Yokoyama H; Kim SW; Mori S; Tanosaki R; Heike Y; Takaue Y
Am J Hematol; 2009 Dec; 84(12):815-20. PubMed ID: 19899134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]